Bank of America’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-53
Closed -$236 8574
2024
Q3
$236 Buy
53
+7
+15% +$47 ﹤0.01% 7531
2024
Q2
$278 Buy
46
+26
+130% +$136 ﹤0.01% 7487
2024
Q1
$164 Sell
20
-4
-17% -$21 ﹤0.01% 7360
2023
Q4
$118 Buy
24
+4
+20% +$26 ﹤0.01% 7401
2023
Q3
$124 Hold
20
﹤0.01% 7458
2023
Q2
$278 Sell
20
-8
-29% -$95 ﹤0.01% 7364
2023
Q1
$332 Buy
28
+2
+8% +$38 ﹤0.01% 7398
2022
Q4
$506 Sell
26
-29
-53% -$494 ﹤0.01% 7430
2022
Q3
$0 Sell
55
-124
-69% -$2.33K ﹤0.01% 8284
2022
Q2
$4K Sell
179
-193
-52% -$5.37K ﹤0.01% 7667
2022
Q1
$13K Sell
372
-43
-10% -$1.31K ﹤0.01% 7669
2021
Q4
$12K Sell
415
-18
-4% -$704 ﹤0.01% 7666
2021
Q3
$21K Sell
433
-197
-31% -$9.89K ﹤0.01% 7377
2021
Q2
$32K Sell
630
-4,251
-87% -$214K ﹤0.01% 6998
2021
Q1
$280K Buy
4,881
+3,411
+232% +$222K ﹤0.01% 5791
2020
Q4
$67K Buy
1,470
+478
+48% +$23K ﹤0.01% 6196
2020
Q3
$50K Sell
992
-682
-41% -$37K ﹤0.01% 6019
2020
Q2
$102K Buy
1,674
+1,654
+8,270% +$100K ﹤0.01% 5665
2020
Q1
$1K Hold
20
﹤0.01% 6748
2019
Q4
$1K Hold
20
﹤0.01% 6989
2019
Q3
$1K Hold
20
﹤0.01% 7156
2019
Q2
$1K Hold
20
﹤0.01% 7081
2019
Q1
$1K Hold
20
﹤0.01% 7014
2018
Q4
$1K Hold
20
﹤0.01% 7002
2018
Q3
$1K Hold
20
﹤0.01% 7164
2018
Q2
$2K Sell
20
-86
-81% -$7.99K ﹤0.01% 6926
2018
Q1
$11K Buy
+106
New +$12.5K ﹤0.01% 6592

Bank of America's ORGS Position: Q4 2024 in Review

Bank of America sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 53 shares — an estimated $236 sold.

Bank of America first reported a position in ORGS in Q1 2018 and held it in 27 quarters. The position peaked at $280K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.

  • Bank of America reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 53 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $236.
  • Bank of America first reported a position in Orgenesis Inc. Common Stock in Q1 2018 and held it in 27 quarters.
  • Bank of America's Orgenesis Inc. Common Stock position peaked at $280K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.